Complex Early Development Studies

Managing First-in-Human (FIH) to Phase Ib

Early-phase clinical studies range from simple to complex, and all must be conducted rapidly while maintaining subject safety and data quality. They are also generally not performed in isolation, and they lay the foundation for future studies to further our understanding of drug metabolism and safety in support of a new drug candidate.